ML files $4 billion fraud suit over cross-border M+A deal
September 2016
MoloLamken filed a suit in New York Supreme Court seeking more than $4 billion in compensatory and punitive damages on behalf of Israel-based global pharmaceutical manufacturer Teva. The case emanates from Teva's acquisition of a major Mexican pharmaceutical company. Read more here.